FindTrial
Sign In

Comparison of Shot Blocker device versus vapocoolant spray for reducing spinal needle pain during spinal anaesthesia in patients undergoing caesarean section

Efficacy of Shot Blocker device versus vapocoolant spray for spinal needle pain relief during spinal anaesthesia in elective caesarean section: A randomized controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113605
Enrollment
90
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Shot Blocker device applied for 10 seconds before spinal needle insertion.: After skin preparation, the Shot Blocker device will be firmly pressed over the intended spinal puncture site

Sponsors

Smt Bhikiben Kanjibhai Shah Medical Institute and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I and II. Full-term primigravida. Scheduled for elective or emergency LSCS under spinal anaesthesia. No previous spinal anaesthesia or lumbar puncture. Able and willing to provide written informed consent. No technically difficult spinal block

Exclusion criteria

Exclusion criteria: Refusal to participate. Allergy to ethyl chloride. Previous spinal anaesthesia. Neurological disease. ASA III or above.

Design outcomes

Primary

MeasureTime frame
Needle-associated pain measured using the 10 point Visual Analogue ScaleTimepoint: Needle-associated pain measured using the 10 point Visual Analogue Scale will be measured immediately within 1 minutes—

Secondary

MeasureTime frame
Patient satisfaction using 3-point Likert scale. Number of spinal attempts. Adverse reactions.Timepoint: Immediately after completion of spinal anaesthesia—

Countries

India

Contacts

Public ContactDr Snehalkumar Prakashbhai Patel

Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre

drsharmasumandeep@gmail.com9313036963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026